nach oben

Metabolic Brain Disease

Erschienen in:

24.12.2016 | Short Communication

Current state of knowledge of hepatic encephalopathy (part IV): Management of Hepatic Encephalopathy by liver support systems

verfasst von: Tarek Hassanein

Erschienen in: Metabolic Brain Disease | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Hepatic Encephalopathy is a devastating complication of End-Stage Liver Disease. In its severe grades it requires extra intervention beyond the standard medical approaches. In this article were view the role of liver support systems in managing hepatic encephalopthy.

Agrawal A, Sharma BC, Sharma P, Sarin SK (2012) Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open-label, randomized controlled trial of lactulose, probiotics, and no therapy. Am J Gastroenterol 107(7):1043–1050CrossRefPubMed

Amodio P, Bemeur C, Butterworth R, et al. (2013) The nutritional management of hepatic encephalopathy in patients with cirrhosis: international society for hepatic encephalopathy and nitrogen metabolism consensus. Hepatology 58(1):325–336CrossRefPubMed

Bajaj JS, Cordoba J, Mullen KD, et al. (2011) Review article: the design of clinical trials in hepatic encephalopathy: an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement. Aliment Pharmacol Ther 33(7):739–747CrossRefPubMedPubMedCentral

Bañares R, Catalina M (2011) “Extracorporeal artificial liver support systems”. Clinical gastroenterology: Chronic Liver Failure. Ed. P Gines. Springer Science + Business Media, LLC. 501–519. Print

Banares R, Nevens F, Larsen FS, et al. (2013) Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the relief trial. Hepatology 57(3):1153–1162CrossRefPubMed

Buckner CD, Clift RA, Volwiler W, Donohue DM, Burnell JM, Saunders FC, Thomas ED (1973) Plasma exchange in patients with fulminant hepatic failure. Arch Intern Med 132:487–492

Cree IC, Straus E, Berger S, Voges P, Scotti P, Atkins P (1973) Plasma exchange in treatment of profound hepatic coma. N Y State J Med 73:569–576

Demeulenaere L, Barbier F, Vermeire P (1969) Plasmapheresis in hepatic coma. Lancet 1:152–153

Dethloff T, Tofteng F, Frederiksen HJ, et al. (2008) Effect of Prometheus liver assist system on systemic hemodynamics in patients with cirrhosis: a randomized controlled study. World J Gastroenterol 14(13):2065–2071CrossRefPubMedPubMedCentral

Evenepoel P, Laleman W, Wilmer A, et al. (2006) Prometheus versus molecular adsorbents recirculating system: comparison of efficacy in two different liver detoxification devices. Artif Organs 30(4):276–284CrossRefPubMed

Ferenci P, Lockwood A, Mullen K, et al. (2002) Hepatic encephalopathy: definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th world congresses of gastroenterology, Vienna, 1998. Hepatology 35:716–721CrossRefPubMed

Freeman JG, Matthewson K, Record CO (1986) Plasmapheresis in acute liver failure. Int J Artif Organs 9:433–438

Hassanein TI, Tofteng F, Brown RS Jr, et al. (2007) Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis. Hepatology 46(6):1853–1862CrossRefPubMed

Hassanein TI, Schade RR, Hepburn IS (2011) Acute-on-chronic liver failure: extracorporeal liver assist devices. Curr Opin Crit Care 17:195–203

Kondrup J, Almdal T, Vilstrup H, Tygstrup N (1992) High volume plasma exchange in fulminant hepatic failure. Int J Artif Organs 15:669–676

Kribben A, Gerken G, Haag S, Herget-Rosenthal S, et al. (2012) Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failure. Gastroenterology 142(4):782–789 e.3CrossRefPubMed

Larsen FS, Hansen BA, Ejlersen E, Secher NH, Clemmesen JO, Tygstrup N, Knudsen GM (1996) Cerebral blood flow, oxygen metabolism and transcranial Doppler sonography during highvolume plasmapheresis in fulminant hepatic failure. Eur J Gastroenterol Hepatol 8:261–265

Laleman W, Wilmer A, Evenepoel P, et al. (2006) Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure. Crit Care 10(4):R108CrossRefPubMedPubMedCentral

Lepore MJ, Stutman LJ, Bonanno CA, Conklin EF, Robilotti JG,McKenna PJ (1972) Plasmapheresis with plasma exchange in hepatic coma. II. Fulminant viral hepatitis as a systemic disease. Arch Intern Med 129:900–907

Merli M, Lucidi C, Pentassuglio I, et al. (2013) Increased risk of cognitive impairment in cirrhotic patients with bacterial infections. J Hepatol 59(2):243–250CrossRefPubMed

Ortiz M, Jacas C, Cordoba J (2005) Minimal hepatic encephalopathy: diagnosis, clinical significance and recommendations. J Hepatol 42(suppl 1):S45–S53CrossRefPubMed

Pugliese F, Novelli G, Poli L, et al. (2008) Hemodynamic improvement as an additional parameter to evaluate the safety and tolerability of the molecular adsorbent recirculating system in liver failure patients. Transplant Proc 40(6):1925–1928CrossRefPubMed

Rahimi RS, Elliott AC, Rockey DC (2013) Altered mental status in cirrhosis: etiologies and outcomes. J Investig Med 61(4):695–700CrossRefPubMed

Sekido H, Matsuo K, Takeda K, Ueda M, Morioka D, Kubota T, Tanaka K, Endo I, Togo S, Shimada H (2004) Usefulness of artificial liver support for pretransplant patients with fulminant hepatic failure. Transplant Proc 36:2355–2356

Splendiani G, Tancredi M, Daniele M, Giammaria U (1990) Treatment of acute liver failure with hemodetoxification techniques. Int J Artif Organs 13:370–374

Stenbog P, Busk T, Larsen FS (2013) Efficacy of liver assisting in patients with hepatic encephalopathy with special focus on plasma exchange. Metab Brain Dis 28(2):333–335CrossRefPubMed

Stepanova M, Mishra A, Venkatesan C, Younossi ZM (2012) In-hospital mortality and economic burden associated with hepatic encephalopathy in the United States from 2005 to 2009. Clin Gastroenterol Hepatol 10(9):1034–1041 e1CrossRefPubMed

Stewart CA, Malinchoc M, Kim WR, Kamath PS (2007) Hepatic encephalopathy as a predictor of survival in patients with end-stage liver disease. Liver Transpl 13(20):1366–1371CrossRefPubMed

Yoshiba M, Sekiyama K, Iwamura Y, Sugata F (1993) Development of reliable artificial liver support (ALS)–plasma exchange in combination with hemodiafiltration using high-performance membranes. Dig Dis Sci 38:469–476

Titel: Current state of knowledge of hepatic encephalopathy (part IV): Management of Hepatic Encephalopathy by liver support systems
verfasst von: Tarek Hassanein
Publikationsdatum: 24.12.2016
Verlag: Springer US
Erschienen in: Metabolic Brain Disease / Ausgabe 2/2017
Print ISSN: 0885-7490
Elektronische ISSN: 1573-7365
DOI: https://doi.org/10.1007/s11011-016-9911-1

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

25.04.2024 | Hypotonie | Nachrichten

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Current state of knowledge of hepatic encephalopathy (part IV): Management of Hepatic Encephalopathy by liver support systems

Abstract

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Update Neurologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2017

Prognostic significance of major lipids in patients with acute ischemic stroke

The bile duct ligated rat: A relevant model to study muscle mass loss in cirrhosis

Erratum to: Activities of genes controlling sphingolipid metabolism in human fibroblasts treated with flavonoids

Urinary metabolic profiling by 1H NMR spectroscopy in patients with cirrhosis may discriminate overt but not covert hepatic encephalopathy

Attenuation of acute restraint stress-induced depressive like behavior and hippocampal alterations with protocatechuic acid treatment in mice

Omega-3 fatty acids and mood stabilizers alter behavioral and oxidative stress parameters in animals subjected to fenproporex administration

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Update Neurologie